Skip to main content Accessibility help
×
Home

Predictors of rapid cognitive decline in Alzheimer's disease: results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of ageing

  • Alessandro Sona (a1) (a2), Ping Zhang (a3), David Ames (a2) (a4), Ashley I. Bush (a5), Nicola T. Lautenschlager (a4) (a6), Ralph N. Martins (a7) (a8), Colin L. Masters (a5) (a9), Christopher C. Rowe (a10), Cassandra Szoeke (a3) (a2), Kevin Taddei (a7) (a8), Kathryn A. Ellis (a4) (a5) and AIBL Research Group...

Abstract

Background: The AIBL study, which commenced in November 2006, is a two-center prospective study of a cohort of 1112 volunteers aged 60+. The cohort includes 211 patients meeting NINCDS-ADRDA criteria for Alzheimer's disease (AD) (180 probable and 31 possible). We aimed to identify factors associated with rapid cognitive decline over 18 months in this cohort of AD patients.

Methods: We defined rapid cognitive decline as a drop of 6 points or more on the Mini-Mental State Examination (MMSE) between baseline and 18-month follow-up. Analyses were also conducted with a threshold of 4, 5, 7 and 8 points, as well as with and without subjects who had died or were too severely affected to be interviewed at 18 months and after, both including and excluding subjects whose AD diagnosis was “possible” AD. We sought correlations between rapid cognitive decline and demographic, clinical and biological variables.

Results: Of the 211 AD patients recruited at baseline, we had available data for 156 (73.9%) patients at 18 months. Fifty-one patients were considered rapid cognitive decliners (32.7%). A higher Clinical Dementia Rating scale (CDR) and higher CDR “sum of boxes” score at baseline were the major predictors of rapid cognitive decline in this population. Furthermore, using logistic regression model analysis, patients treated with a cholinesterase inhibitor (CheI) had a higher risk of being rapid cognitive decliners, as did males and those of younger age.

Conclusions: Almost one third of patients satisfying established research criteria for AD experienced rapid cognitive decline. Worse baseline functional and cognitive status and treatment with a CheI were the major factors associated with rapid cognitive decline over 18 months in this population.

Copyright

Corresponding author

Correspondence should be addressed to: Professor David Ames, Director, National Ageing Research Institute, P.O. Box 2127, Royal Melbourne Hospital, Victoria 3050, Australia. Phone: +61 3 83872305; Fax: +61 3 93874030. Email: dames@unimelb.edu.au.

References

Hide All
Access Economics (2009). Keeping Dementia Front of Mind: Incidence and Prevalence 2009–2050. Canberra: Alzheimer's Australia.
Atchison, T. B., Bradshaw, M. and Massman, P. J. (2007). Investigation of profile difference between Alzheimer's disease patients declining at different rates: examination of baseline neuropsychological data. Archives of Clinical Neuropsychology, 19, 10071015.
Birks, J. (2006). Cholinesterase inhibitors for Alzheimer's disease. Cochrane Database of Systematic Reviews, 1, CD005593.
Bhargava, D., Weiner, M. F., Hynan, L. S., Diaz-Arrastia, R. and Lipton, A. M. (2006). Vascular disease and risk factors, rate of progression, and survival in Alzheimer's disease. Journal of Geriatric Psychiatry and Neurology, 19, 7882.
Brodaty, H., Woodward, M., Boundy, K., Ames, D. and Balshaw, R. (2011). Patients in Australian memory clinics: baseline characteristics and predictors of decline at 6 months. International Psychogeriatrics. Epublished ahead of print, doi:10.107/S1041610211000688.
Burns, A., Jacoby, R. and Levy, R. (1991). Progression of cognitive impairment in Alzheimer's disease. Journal of the American Geriatrics Society, 39, 3945.
Capitani, E., Cazzaniga, R., Francescani, A. and Spinnler, H. (2004). Cognitive deterioration in Alzheimer's disease: is the early course predictive of the later stages? Neurological Sciences, 25, 198204.
Carcallion, L., Peres, K, Pere, J. J., Helmer, C., Orgogozo, J. M., Dartigues, J. F. (2007). Fast cognitive decline at the time of dementia diagnosis: a major prognostic factor for survival in the community. Dementia and Geriatric Cognitive Disorders, 24, 138145.
Clark, C. M. et al. (1999). Variability in annual Mini-Mental State Examination score in patients with probable Alzheimer disease. Archives of Neurology, 56, 857862.
Doody, R. S., Massman, P. and Dunn, K. (2001). A method for estimating progression rates in Alzheimer's disease. Archives of Neurology, 58, 449454.
Doody, R. S., Pavlik, V., Massman, P., Rountree, S., Darby, E. and Chan, W. (2010). Predicting progression of Alzheimer's disease. Alzheimer's Research and Therapy, 2, 29.
Ellis, K. A., et al. (2009). The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease. International Psychogeriatrics, 21, 672687.
Flicker, L. (2010). Screening and assessment instruments for the detection and measurement of cognitive impairment. In Ames, D., Burns, A., , A. and O'Brien, J. (eds.), Dementia 4th edn. (p. 57). London: Hodder Arnold.
Folstein, M. F., Folstein, S. E. and McHugh, P. R. (1975). “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189198.
Gillette-Guyonnette, S., et al. (2006). Outcome of Alzheimer's disease: potential impact of cholinesterase inhibitors. Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 61, 516520.
Holtzer, R. et al. (2003). The rate of cognitive decline and risk of reaching clinical milestones in Alzheimer's disease. Archives of Neurology, 60, 11371142.
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D. and Stadlan, E. M. (1984). Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease. Neurology, 34, 939944.
Mendiondo, M. S., Ashford, J. W., Kryscio, R. J. and Schmitt, F. A. (2000) Modeling Mini Mental State Examination changes in Alzheimer's disease. Statistical Medicine, 19, 16071616.
Morris, J. C. (1993). The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology, 43, 24122414.
Morris, J. C., et al. (1993). The consortium to establish a registry for Alzheimer's disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease. Neurology, 43, 24572465.
Musicco, M. et al. (2010). Neuropsychological predictors of rapidly progressing patients with Alzheimer's disease. Dementia and Geriatric Cognitive Disorders, 30, 219228
O'Hara, R. et al. (2002). Which Alzheimer patients are at risk for rapid cognitive decline? Journal of Geriatric Psychiatry and Neurology, 15, 233238.
Ousset, P. J., Nourhashemi, F., Reynish, E. and Vellas, B. (2008). Nutritional status is associated with disease progression in very mild Alzheimer disease. Alzheimer Disease and Associated Disorders, 22, 6671.
Petersen, R. C. et al. (2009). Mild cognitive impairment: ten years later. Archives of Neurology, 66, 14471455.
R Development Core Team (2010). R: a Language and Environment for Statistical Computing. Vienna: R Foundation for Statistical Computing. See http://www.R-project.org.
Rowe, C. et al. (2010). Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging. Neurobiology of Aging, 31, 12751283.
Schneider, L. S., Insel, P. S. and Weiner, M. W.for the Alzheimer's Disease Neuroimaging Initiative. (2011). Treatment with cholinesterase inhibitors and memantine of patients in the Alzheimer's Disease Neuroimaging Initiative. Archives of Neurology, 68, 5866.
Sona, A., Ellis, K. and Ames, D. (submitted). Rapid cognitive decline in Alzheimer's disease: a selective review of the literature. Submitted to International Psychogeriatrics.
Soto, M. E., Gillette-Guyonnet, S., Vellas, B.and the REAL.FR group. (2005). Rapid cognitive decline: searching for a definition and predictive factor among elderly with Alzheimer's disease. Journal of Nutrition, Health and Aging, 9, 158161.
Soto, M. E. et al. (2008a). Rapid cognitive decline in Alzheimer disease. Consensus paper Journal of Nutrition Health and Aging, 12, 703713.
Soto, M. E. et al. (2008b). Predictive value of rapid decline in Mini Mental State Examination in clinical practice for prognosis in Alzheimer's disease. Dementia and Geriatric Cognitive Disorders, 26, 109116.
Winblad, B. et al. (2004). Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. Journal of Internal Medicine, 256, 240246.

Keywords

Predictors of rapid cognitive decline in Alzheimer's disease: results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of ageing

  • Alessandro Sona (a1) (a2), Ping Zhang (a3), David Ames (a2) (a4), Ashley I. Bush (a5), Nicola T. Lautenschlager (a4) (a6), Ralph N. Martins (a7) (a8), Colin L. Masters (a5) (a9), Christopher C. Rowe (a10), Cassandra Szoeke (a3) (a2), Kevin Taddei (a7) (a8), Kathryn A. Ellis (a4) (a5) and AIBL Research Group...

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed